SASSI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 3.936
EU - Europa 2.729
AS - Asia 2.215
SA - Sud America 278
OC - Oceania 63
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.253
Nazione #
US - Stati Uniti d'America 3.678
CN - Cina 1.154
IT - Italia 900
DE - Germania 340
GB - Regno Unito 313
JP - Giappone 221
CA - Canada 152
FR - Francia 136
ES - Italia 127
PL - Polonia 123
TR - Turchia 123
IE - Irlanda 122
SE - Svezia 117
KR - Corea 106
TW - Taiwan 104
IN - India 103
MX - Messico 83
FI - Finlandia 74
SG - Singapore 74
BR - Brasile 61
PE - Perù 61
AT - Austria 59
CH - Svizzera 57
HK - Hong Kong 56
UA - Ucraina 56
BE - Belgio 55
NL - Olanda 53
AU - Australia 52
CO - Colombia 52
RO - Romania 43
IL - Israele 37
TH - Thailandia 37
CL - Cile 34
VN - Vietnam 29
EC - Ecuador 28
ID - Indonesia 24
SA - Arabia Saudita 24
RU - Federazione Russa 22
AR - Argentina 21
CZ - Repubblica Ceca 21
DK - Danimarca 21
IR - Iran 19
GR - Grecia 17
HU - Ungheria 16
PT - Portogallo 16
LB - Libano 13
JO - Giordania 12
NZ - Nuova Zelanda 11
PH - Filippine 11
SK - Slovacchia (Repubblica Slovacca) 11
GY - Guiana 10
MO - Macao, regione amministrativa speciale della Cina 10
MY - Malesia 10
PS - Palestinian Territory 10
AE - Emirati Arabi Uniti 9
PR - Porto Rico 9
LV - Lettonia 7
NG - Nigeria 6
NI - Nicaragua 6
SN - Senegal 6
EG - Egitto 5
KZ - Kazakistan 5
PK - Pakistan 5
QA - Qatar 5
BO - Bolivia 4
SI - Slovenia 4
UY - Uruguay 4
ZA - Sudafrica 4
BA - Bosnia-Erzegovina 3
BD - Bangladesh 3
EE - Estonia 3
NO - Norvegia 3
TN - Tunisia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
IQ - Iraq 2
LT - Lituania 2
MK - Macedonia 2
MN - Mongolia 2
RS - Serbia 2
SV - El Salvador 2
UZ - Uzbekistan 2
AM - Armenia 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
LK - Sri Lanka 1
MA - Marocco 1
PA - Panama 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UG - Uganda 1
Totale 9.253
Città #
Ann Arbor 540
Chandler 255
Fairfield 241
Beijing 224
Houston 172
Ashburn 154
Shanghai 150
Woodbridge 144
Torino 130
Seattle 125
Dublin 105
Wilmington 104
Redwood City 100
Guangzhou 95
Cambridge 92
Milan 69
Turin 67
Dearborn 64
Tokyo 61
Lima 51
Pisa 48
Vienna 48
Taipei 43
Nyköping 40
New York 38
Dundee 37
Warsaw 37
Nanjing 36
Rome 36
Villeurbanne 34
Wuhan 33
Istanbul 32
Singapore 32
Hangzhou 30
Princeton 30
Toronto 30
London 29
Los Angeles 29
Ithaca 27
Medford 27
Chengdu 26
Jacksonville 25
Bogotá 24
Changsha 24
Paris 24
San Diego 24
Zurich 24
Boardman 23
Brussels 23
Seoul 23
Stuttgart 22
Chicago 21
Fremont 21
Genoa 21
Iowa City 20
Shenzhen 20
Chongqing 19
Florence 19
Luni 19
Shenyang 19
Bangkok 18
Bucharest 18
Xian 18
Boston 17
Brooklyn 17
Helsinki 17
Marcellus 17
Ottawa 17
Santiago 17
Barcelona 16
Lappeenranta 16
Washington 16
Bengaluru 15
Fuzhou 15
Medellín 15
Tianjin 15
Zhengzhou 15
Berlin 14
Bologna 14
Bursa 14
Central 14
Changchun 14
Dong Ket 14
Jinan 14
Manchester 13
Concepción 12
Hyderabad 12
Ankara 11
Carrara 11
Denver 11
Duncan 11
Jeddah 11
Leuven 11
Madrid 11
Naples 11
Quito 11
Sydney 11
Guayaquil 10
Hong Kong 10
Melbourne 10
Totale 4.634
Nome #
High-dose Vitamin C enhances cancer immunotherapy 4.191
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 695
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 650
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 607
The genomic landscape of response to EGFR blockade in colorectal cancer 337
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 314
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 301
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 278
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 225
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 221
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 220
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 207
Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals 179
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 167
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. 166
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. 126
Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas 108
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 91
MET SIGNALING REGULATES GROWTH, REPOPULATING POTENTIAL AND BASAL CELL-FATE COMMITMENT OF MAMMARY LUMINAL PROGENITORS: IMPLICATIONS FOR BASAL-LIKE BREAST CANCER. 83
Met as a potential therapeutic target in basal-like breast cancer 71
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 67
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling 48
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer 24
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer 19
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 14
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis 3
Totale 9.412
Categoria #
all - tutte 16.436
article - articoli 0
book - libri 0
conference - conferenze 1.043
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020789 67 35 40 114 50 136 78 60 76 64 40 29
2020/20211.156 34 75 108 77 61 100 131 101 139 116 62 152
2021/20221.995 146 172 181 195 185 149 169 173 176 121 195 133
2022/20231.996 127 119 148 152 117 249 175 168 242 125 227 147
2023/20241.961 200 165 174 195 187 157 118 184 56 196 186 143
2024/202588 88 0 0 0 0 0 0 0 0 0 0 0
Totale 9.412